THE $MSTR OPPORTUNITY IS HERE
Strong bounce zone in play here.
I’m eyeing selling leap puts to collect premium
🚨 $ALOY COULD BE POSITIONING ITSELF IN ONE OF AMERICA’S MOST IMPORTANT INDUSTRIES! 🇺🇸
The U.S. wants to reduce its dependence on foreign countries for critical minerals.
And that’s exactly where $ALOY is looking to make its mark. 👀
Here’s why it’s catching my attention:
🇺🇸 U.S. Army Connection – A term sheet for a potential heavy rare earth processing facility.
🏭 Domestic Production – Working toward an American supply chain for materials used in military equipment and advanced technology.
👔 Experienced Leadership – A new COO brings valuable industry expertise to help move the business forward.
🧲 Bigger Ambitions – The goal is to build an operation that connects raw materials all the way through to finished magnets.
The opportunity is significant, but execution will be everything.
With national security and American manufacturing back in focus, $ALOY is a ticker worth watching closely.
Who’s watching $ALOY? 👀
CommunicatedDisclaimer: stockresearchtoday.com/aloy/
3
181
🚨 $AIBZ: THE AI POWER PLAY HIDING IN PLAIN SIGHT 🚨
AI is not just about chips and software.
It needs data centers.
And data centers need one thing above all else:
Massive amounts of power. ⚡
That’s why I’m watching $AIBZ Bitzero Holdings.
The company is building sustainable energy and data center infrastructure designed for:
✅ AI workloads
✅ High Performance Computing
✅ Blockchain operations
✅ Next-gen digital infrastructure
While most traders chase the obvious AI names…
$AIBZ is positioned closer to the backbone of the AI boom.
No power = no AI.
No data centers = no scale.
This is the type of infrastructure angle I think more people will start paying attention to.
Keeping $AIBZ on watch. 👀
CommunicatedDisclaimer: stockresearchtoday.com/aibz/
🚨 $AIBZ COULD BE ONE OF THE AI INFRASTRUCTURE PLAYS FLYING UNDER THE RADAR
AI is creating a massive demand for power + data center capacity…
And Bitzero $AIBZ is positioning itself directly in that trend. 👀
Why it’s on my radar:
- Building large, renewable powered data centers
- Expanding into AI/HPC infrastructure
- NVIDIA Blackwell B300 GPUs already deployed
- Significant additional capacity planned across its sites
But the BIG story…
$AIBZ announced a binding 15-year agreement with OneQode for 110 MW of capacity at its Norway site.
The company says the agreement represents approximately $2.6 BILLION in revenue over the life of the lease.
Now $AIBZ is progressing site readiness and leasing efforts as it looks to turn that infrastructure into long-term revenue.
AI needs chips.
AI needs data centers.
And most importantly… AI needs POWER.
That’s why I’m watching AIBZ closely here.
CommunicatedDisclaimer:stockresearchtoday.com/aibz/
2
3
425
🚨 $GRML IS SITTING ON A HUGE UNTAPPED OPPORTUNITY 🚨
Greenland Mines is developing one of the world’s largest undeveloped palladium, gold & platinum deposits.
Here’s why it has my attention 👀
⛏️ Massive precious metals project in Greenland
🇬🇱 Located in a region becoming increasingly important for Western critical-mineral supply
💰 Fresh capital gives the company more firepower to advance the project
🚁 Drilling and development work is actively progressing in 2026
📈 Management is looking to significantly expand the known resource
PLUS $GRML also has a biotech division developing treatments for ALS & Alzheimer’s
KEY LEVELS I’M WATCHING:
Support: $8.19
➡️ $11.50
➡️ $15.81
➡️ $18.15
Big resource. Fresh funding. Active development.
$GRML is firmly on my radar. 👀
CommunicatedDisclaimer:chartingdaily.com/greenland
3
5
870
🚨 $OPTH REPEAT DEMAND IS STARTING TO SHOW 🚨
Optimi Health isn’t just developing psychedelic medicines and it’s already shipping them commercially.
• Another 1,000 psilocybin capsules sent to Australia
• Now the third commercial shipment since Sept. 2025
• Repeat orders are beginning to contribute to revenue
• Production handled through its own GMP-licensed operation
The part I’m watching now: whether these repeat shipments continue to scale. 👀
$OPTH remains on my radar.
CommunicatedDisclaimer: stockresearchtoday.com/opth/
2
3
268
🚨 $OPTH: PSYCHEDELIC PIPELINE EXPANSION! 🧠
Optimi Health is taking its psychedelic medicine business to the NEXT LEVEL!
🔥 Phase 2 psilocybin depression study
🔥 Phase 3 MDMA/PTSD trial
🔥 New clinical leadership appointed
🔥 Patient enrollment targeted for 2027
Already manufacturing psychedelic medicines.
$OPTH now has multiple clinical milestones on the horizon! 🚀
2
4
270
🚨 $OPTH: A MAJOR PSYCHEDELIC MEDICINE OPPORTUNITY? 🧠
Optimi Health is expanding its commercial drug business while advancing TWO major clinical programs
•supplying psychedelic medicines in Australia
•Phase 2 psilocybin depression trial planned
•New psilocybin production milestone achieved!
Commercial sales + upcoming clinical catalysts.
$OPTH IS ON MY RADAR!
CommunicatedDisclaimer:stockresearchtoday.com/opth/
5
4
267
🚨 $FBDT MAJOR DRONE MILESTONE! 🇺🇸
First Breach just completed its FIRST untethered flight of its proprietary drone prototype!
🔥 Successful flight testing
🔥 Initial prototypes targeted for Q4 2026
🔥 Production scaling planned for Q2 2027
🔥 Targeting 2,500+ drones per WEEK!
From prototype to potential mass production, $FBDT is making progress in American made defense technology.
ONE TO WATCH! 🇺🇸
CommunicatedDisclaimer:stockresearchtoday.com/fbdt/
🚨 $FBDT U.S. DEFENSE PRODUCTION IS RAMPING 🇺🇸
First Breach is scaling ammunition + drone manufacturing.
Key numbers 👀
• 3-year ammo supply agreement
• Targeting 8M+ rounds/month by April 2027
• Capacity expanded to 20M rounds/month
• First strike-drone prototype completed
• Targeting 2,500+ drones/week in 2027
🎯 NEXT CATALYSTS:
Ammo deliveries, production growth, drone testing + potential new defense contracts.
$FBDT is one to watch. 👀
Communicated Disclaimer: stockresearchtoday.com/fbdt/
3
5
354
Dylan Humphreys | Option Seller retweeted
$2B Dealmaker Turned Biotech CEO: Jared Kelly on the Fast Track to a Cancer Cure xitter.cf/i/broadcasts/1dKrPrwkv…
At what price does $SOFI become a generational buy?
🚨 GET FUNDED TO TRADE OPTIONS 55% OFF 🚨
Want to trade options with more buying power without putting up all the capital yourself? 👀
Strix Options Funding offers funded accounts built specifically for options traders.
🔥 Use code THETAGANG for 55% OFF prop firm accounts.
More capital. More opportunity. Less personal capital at risk.
👉 Check out Strix Options Funding below.
CODE: THETAGANG
strixoptionsfunding.com/?ref…
🚨 $BXBL IS ONE TO WATCH 🚨
BOXABL is building factory-made modular homes aimed at making housing faster and more affordable.
Why I’m watching:
• 846 Casitas manufactured
• 335 delivered across 10 states
• 341 units under contract
• ~15.6M mid-float
• Large volume gap overhead
👀 Next Catalyst:
BOXABL says its new self-leveling travel trailer has around 5,000 pre-orders, with launch expected in 2027.
$BXBL ON MY RADAR.
Communicated Disclaimer: tinyurl.com/THETAGANGDISCLAI…
🚨 $BXBL BULLISH REVERSAL SETUP IS TAKING SHAPE 🚨
BXBL is bringing mass production to housing, using factory built modular Boxes that fold for transportation and can be rapidly installed on site.
The chart is starting to get interesting.
📈 BULLISH TECHNICALS
• Strong bounce from the demand zone
• Price has reclaimed both short-term EMAs
• 5 EMA crossing above the 13 EMA
• Testing the major descending trendline
• Breakout confirmation could open the door toward $4.80–$5.00+
Some notable fundamental improvements underneath the setup:
💰 Q1 revenue jumped to $1.56M vs. $123K YoY
💰 Net loss improved to $7.58M vs. $10.26M YoY
💰 Cash + equivalents stood at $22.3M at Q end
$BXBL ON BREAKOUT WATCH. 👀
CommunicatedDisclaimer:tinyurl.com/THETAGANGDISCLAI…
🚨 $SOFI IS BUILDING A SERIOUS BULLISH SETUP
This chart is getting hard to ignore. 👀
📈 Massive rounding bottom forming on the daily
📈 Price pushing back toward the $19 breakout zone
📈 Higher lows continuing to build underneath price
📈 Strong volume support sitting around $17–$18
📈 Weekly MACD momentum is curling higher
The key level for me is $19.
A clean breakout and hold above that area could confirm the larger reversal and open the door for a move back into the $20s.
After months of basing, $SOFI finally looks like it could be preparing for its next expansion.
$19 BREAKS… THINGS COULD GET INTERESTING FAST. 👀
🚨 $ONCY IS SITTING AT A VERY INTERESTING SPOT
Friday gave bulls exactly what they wanted to see.
$ONCY reacted strongly from the $0.72–$0.80 support zone, bouncing roughly 7% into the close.
Why I’m watching:
• Support continues to hold
• FDA Fast Track catalyst remains fresh
• Strong early GI cancer data
• Price still compressing beneath major downtrend resistance
Now the focus shifts to $0.90–$1.00.
A clean break through that area could be the technical confirmation bulls have been waiting for.
CommunicatedDisclaimer:stockresearchtoday.com/oncy/
🚨 $ONCY JUST LANDED FDA FAST TRACK + STRONG TECHNICALS
Oncolytics Biotech is developing a platform targeting some of the toughest GI cancers.
Why I’m watching:
BULLISH TA SETUP
$ONCY is compressing inside a large descending wedge while repeatedly defending the $0.72–$0.80 support zone.
What I’m watching:
• Higher reaction off support
• Break above $0.90
• Major descending trendline near $1.00
• Trendline breakout could open a move toward $1.20 → $1.50
The tighter this setup gets, the more interesting the breakout becomes.
$ONCY is sitting at a key technical inflection point.
CommunicatedDisclaimer:stockresearchtoday.com/oncy/
🚨 $BSEM IS SITTING ON MAJOR SUPPORT 👀
This is one I’m watching closely.
BioStem is expanding beyond chronic wound care after acquiring BioTissue’s Neox® and Clarix® business, giving it exposure to the hospital, surgical, and acute wound care markets.
Why it stands out:
✅ ~$29M in 2025 sales
✅ Expanding into higher-value markets
✅ pursuing a potential Nasdaq uplisting
✅ Seven consecutive quarters of positive adjusted EBITDA (through Q3 2025)
If support holds here, this could be an interesting level to watch.
📈 A prior Zacks Small-Cap Research report (published November 13, 2024) assigned a $25.50 price target, but investors should verify whether that target remains current before relying on it. (BioStem Technologies)
Not financial advice. Do your own research.
Disclaimer: bit.ly/4trWQFV
$SOFI AT $15 SAME PRICE. COMPLETELY DIFFERENT COMPANY.
Five years ago at $15 ⤵️
- 2.5M members
- $300M gross profit
Today at $15 ⤵️
- 15.8M members
- $2.5B gross profit
The stock hasn't moved.
The business grew 6x on members and nearly 8x on gross profit.
That's not a broken company.
That's a mispriced one.
$SOFI IS BACK AT MAJOR SUPPORT WHILE CEO BUYS
Price is sitting at $15.30.
Same level that's held multiple times going back over a year.
And the CEO is putting real money behind it.
Anthony Noto has bought over 130,000 shares in 2026 across five separate open-market purchases.
$1M+ in a single trade in March at $17.88.
Another $500K at $17.32.
More buys at $15.73, $16.00, and $18.06.
Total spent: ~$2.25 million.
He's buying above current price, which means he's sitting on unrealized losses.
And he's still buying.
That's not noise. That's conviction.
$15 support has a history. The CEO has a track record.
Watching this level closely.





















